VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
PsychRounds: The Psychiatry Podcast
00:00
Efficacy data and long‑term outcomes
Bradley Miller reviews trial effect sizes, NNTs, dose dependence, CONNECT trials, and sustained benefit in open‑label studies.
Play episode from 13:53
Transcript
